However, he emphasised that the current evidence is early and observational, and there is no national or international guidance requiring any change to how these medications are managed before scans
The aim is to offer efficient treatment to adults suffering from obesity, considering their individual characteristics, preferences and living conditions
If gastrointestinal symptoms become intolerable, healthcare providers may recommend temporarily pausing dose escalation, maintaining the current dose longer before increasing, or even reducing to a previous dose until symptoms improve
The pipeline is very full of weight-loss drugs, and [the] pharma [industry] is focusing on this class of drugs it wont be going away anytime soon, Midlam said
There is no difference in glucose reduction compared to the add-on of GLP1-RAs first or the SGLT2is first
The deal team had negotiated with everyone it could see